These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29444979)

  • 1. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.
    Stafford WC; Peng X; Olofsson MH; Zhang X; Luci DK; Lu L; Cheng Q; Trésaugues L; Dexheimer TS; Coussens NP; Augsten M; Ahlzén HM; Orwar O; Östman A; Stone-Elander S; Maloney DJ; Jadhav A; Simeonov A; Linder S; Arnér ESJ
    Sci Transl Med; 2018 Feb; 10(428):. PubMed ID: 29444979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin Reductase Inhibition for Cancer Therapy.
    Gencheva R; Arnér ESJ
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():177-196. PubMed ID: 34449246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine restriction exposes a targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase.
    Malin D; Lee Y; Chepikova O; Strekalova E; Carlson A; Cryns VL
    Breast Cancer Res Treat; 2021 Dec; 190(3):373-387. PubMed ID: 34553295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma.
    Lee D; Xu IM; Chiu DK; Leibold J; Tse AP; Bao MH; Yuen VW; Chan CY; Lai RK; Chin DW; Chan DF; Cheung TT; Chok SH; Wong CM; Lowe SW; Ng IO; Wong CC
    Hepatology; 2019 Apr; 69(4):1768-1786. PubMed ID: 30561826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rheumatoid arthritis drug auranofin exerts potent anti-lymphoma effect by stimulating TXNRD-mediated ROS generation and inhibition of energy metabolism.
    Yang M; Liu J; Li J; Wen S; Hu Y; Lu W; Liu J; Huang P; Liu P
    Redox Biol; 2024 Sep; 75():103245. PubMed ID: 38909408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for assaying irreversible inhibitors of thioredoxin reductase 1.
    Sun S; Liu H; Shi W; Zhou H; Wu H; Xu W; Xu J
    STAR Protoc; 2024 Sep; 5(3):103235. PubMed ID: 39116197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial thioredoxin reductase 2 is elevated in long-lived primate as well as rodent species and extends fly mean lifespan.
    Pickering AM; Lehr M; Gendron CM; Pletcher SD; Miller RA
    Aging Cell; 2017 Aug; 16(4):683-692. PubMed ID: 28474396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
    Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
    Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium-independent antioxidant and anti-inflammatory effects of thioredoxin reductase inhibition in alveolar macrophages.
    Staples S; Wall SB; Li R; Tipple TE
    Life Sci; 2020 Oct; 259():118285. PubMed ID: 32798556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guiding bar motif of thioredoxin reductase 1 modulates enzymatic activity and inhibitor binding by communicating with the co-factor FAD and regulating the flexible C-terminal redox motif.
    Shi W; Sun S; Liu H; Meng Y; Ren K; Wang G; Liu M; Wu J; Zhang Y; Huang H; Shi M; Xu W; Ma Q; Sun B; Xu J
    Redox Biol; 2024 Apr; 70():103050. PubMed ID: 38277963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer.
    Dai B; Yoo SY; Bartholomeusz G; Graham RA; Majidi M; Yan S; Meng J; Ji L; Coombes K; Minna JD; Fang B; Roth JA
    Cancer Res; 2013 Sep; 73(17):5532-43. PubMed ID: 23824739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive chemical proteomics analyses reveal that the new TRi-1 and TRi-2 compounds are more specific thioredoxin reductase 1 inhibitors than auranofin.
    Sabatier P; Beusch CM; Gencheva R; Cheng Q; Zubarev R; Arnér ESJ
    Redox Biol; 2021 Nov; 48():102184. PubMed ID: 34788728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol regulates the thioredoxin antioxidant system in the mouse uterus.
    Deroo BJ; Hewitt SC; Peddada SD; Korach KS
    Endocrinology; 2004 Dec; 145(12):5485-92. PubMed ID: 15345672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells.
    Li H; Hu J; Wu S; Wang L; Cao X; Zhang X; Dai B; Cao M; Shao R; Zhang R; Majidi M; Ji L; Heymach JV; Wang M; Pan S; Minna J; Mehran RJ; Swisher SG; Roth JA; Fang B
    Oncotarget; 2016 Jan; 7(3):3548-58. PubMed ID: 26657290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thioredoxin reductase inhibitor auranofin induces heme oxygenase-1 in lung epithelial cells via Nrf2-dependent mechanisms.
    Dunigan K; Li Q; Li R; Locy ML; Wall S; Tipple TE
    Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L545-L552. PubMed ID: 30024305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer.
    Delgobo M; Gonçalves RM; Delazeri MA; Falchetti M; Zandoná A; Nascimento das Neves R; Almeida K; Fagundes AC; Gelain DP; Fracasso JI; Macêdo GB; Priori L; Bassani N; Bishop AJR; Forcelini CM; Moreira JCF; Zanotto-Filho A
    Free Radic Biol Med; 2021 Dec; 177():58-71. PubMed ID: 34673143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia.
    Wall SB; Wood R; Dunigan K; Li Q; Li R; Rogers LK; Tipple TE
    Oxid Med Cell Longev; 2019; 2019():7945983. PubMed ID: 30805084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium supplementation of lung epithelial cells enhances nuclear factor E2-related factor 2 (Nrf2) activation following thioredoxin reductase inhibition.
    Tindell R; Wall SB; Li Q; Li R; Dunigan K; Wood R; Tipple TE
    Redox Biol; 2018 Oct; 19():331-338. PubMed ID: 30212802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development.
    Jakupoglu C; Przemeck GK; Schneider M; Moreno SG; Mayr N; Hatzopoulos AK; de Angelis MH; Wurst W; Bornkamm GW; Brielmeier M; Conrad M
    Mol Cell Biol; 2005 Mar; 25(5):1980-8. PubMed ID: 15713651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Selenoprotein Thioredoxin Reductase 1 for Anticancer Therapy.
    Arnér ESJ
    Adv Cancer Res; 2017; 136():139-151. PubMed ID: 29054416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.